The impact of topical mydriatic ophthalmic solutions on retinal vascular reactivity and blood flow

Experimental Eye Research

Volumn 112, Issue , 2013, Pages 134-138

  Tsui, Edmund ^a   Sehi, Mitra ^b   Cheng, Richard W F ^a   Wan, Jennifer ^a,c   Wong, Tien ^a,c   Dorner, Stephanie ^d,e   Fisher, Joseph A ^d,e   Hudson, Christopher ^a,c  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WATERLOO   (Canada)

^d Thornhill Research Inc   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Blood flow; Mydriatic; Retina; Vascular reactivity

Indexed keywords

CYCLOPENTOLATE; EYE DROPS; MYDRIATIC AGENT; MYDRIATIC OPHTHALMIC SOLUTION; PHENYLEPHRINE; TROPICAMIDE; UNCLASSIFIED DRUG;

ADULT; ARTERIOLE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD FLOWMETER; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; DIASTOLIC BLOOD PRESSURE; EYE; FEMALE; HEMODYNAMICS; HUMAN; INTRAOCULAR PRESSURE; MALE; MYDRIASIS; PRIORITY JOURNAL; PUPIL; RETINA BLOOD FLOW; RETINAL VASCULAR REACTIVITY; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, TOPICAL; ARTERIOLES; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CYCLOPENTOLATE; DRUG COMBINATIONS; FEMALE; HUMANS; HYPEROXIA; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; MYDRIATICS; OPHTHALMIC SOLUTIONS; PHENYLEPHRINE; PUPIL; REGIONAL BLOOD FLOW; RETINAL ARTERY; TROPICAMIDE; YOUNG ADULT;

EID: 84879148107     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.05.005     Document Type: Article

References (31)

1. Azizi B., Buehler H., Venkataraman S.T., Hudson C. Impact of simulated light scatter on the quantitative, noninvasive assessment of retinal arteriolar hemodynamics. J.Biomed. Opt. 2007, 12:034021.
2. Del Amo E.M., Urtti A. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov. Today 2008, 13:135-143.
3. Dumskyj M.J., Eriksen J.E., Doré C.J., Kohner E.M. Autoregulation in the human retinal circulation: assessment using isometric exercise, laser Doppler velocimetry, and computer-assisted image analysis. Microvasc. Res. 1996, 51:378-392.
4. Eyeson-Annan M.L., Hirst L.W., Battistutta D., Green A. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide. Ophthalmology 1998, 105:726-732.
5. Feke G.T., Tagawa H., Deupree D.M., Goger D.G., Sebag J., Weiter J.J. Blood flow in the normal human retina. Invest. Ophthalmol. Vis. Sci. 1989, 30:58-65.
6. Garhofer G., Werkmeister R., Dragostinoff N., Schmetterer L. Retinal blood flow in healthy young subjects. Invest. Ophthalmol. Vis. Sci. 2012, 53:698-703.
7. Gilmore E.D., Hudson C., Nrusimhadevara R.K., Harvey P.T., Mandelcorn M., Lam W.C., Devenyi R.G. Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation in early sight-threatening diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2007, 48:1744-1750.
8. Gilmore E.D., Hudson C., Preiss D., Fisher J. Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2912-H2917.
9. Grunwald J.E., Riva C.E., Kozart D.M. Retinal circulation during a spontaneous rise of intraocular pressure. Br. J. Ophthalmol. 1988, 72:754-758.
10. Guan K., Hudson C., Flanagan J.G. Variability and repeatability of retinal blood flow measurements using the Canon Laser Blood Flowmeter. Microvasc. Res. 2003, 65:145-151.
11. Huber M.J., Smith S.A., Smith S.E. Mydriatic drugs for diabetic patients. Br. J. Ophthalmol. 1985, 69:425-427.
12. Jeppesen P., Sanye-Hajari J., Bek T. Increased blood pressure induces a diameter response of retinal arterioles that increases with decreasing arteriolar diameter. Invest. Ophthalmol. Vis. Sci. 2007, 48:328-331.
13. Kisilevsky M., Mardimae A., Slessarev M., Han J., Fisher J., Hudson C. Retinal arteriolar and middle cerebral artery responses to combined hypercarbic/hyperoxic stimuli. Invest. Ophthalmol. Vis. Sci. 2008, 49:5503-5509.
14. Kur J., Newman E.A., Chan-Ling T. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog. Retin. Eye Res. 2012, 31:377-406.
15. Laties A.M. Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. Arch. Ophthalmol. 1967, 77:405-409.
16. Laties A.M., Jacobowitz D. Acomparative study of the autonomic innervation of the eye in monkey, cat, and rabbit. Anat. Rec. 1966, 156:383-395.
17. Manny R.E., Fern K.D., Zervas H.J., Cline G.E., Scott S.K., White J.M., Pass A.F. 1% Cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response. Optom. Vis. Sci. 1993, 70:651-665.
18. Maurice D.M., Mishima S. Ocular pharmacokinetics. Handbook of Experimental Pharmacology 1984, vol. 69:16-119. Springer Verlag, Berlin-Heidelberg.
19. Netland P.A., Siegner S.W., Harris A. Color Doppler ultrasound measurements after topical and retrobulbar epinephrine in primate eyes. Invest. Ophthalmol. Vis. Sci. 1997, 38:2655-2661.
20. Park J.-H., Lee Y.-C., Lee S.-Y. The comparison of mydriatic effect between two drugs of different mechanism. Korean J. Ophthalmol. 2009, 23:40-42.
21. Pournaras C.J., Rungger-Brändle E., Riva C.E., Hardarson S.H., Stefansson E. Regulation of retinal blood flow in health and disease. Prog. Retin. Eye Res. 2008, 27:284-330.
22. Riva C.E. Retinal blood flow. Arch. Ophthalmol. 1979, 97:173-175.
23. Riva C.E., Grunwald J.E., Sinclair S.H., Petrig B.L. Blood velocity and volumetric flow rate in human retinal vessels. Invest. Ophthalmol. Vis. Sci. 1985, 26:1124-1132.
24. Schmetterer L., Garhöfer G. Retinal blood flow. Retinal Vascular Disease 2007, 167-174. Springer Verlag, Heidelberg, Germany. A.M. Joussen, T.W. Gardner, B. Kirchhof, S.J. Ryan (Eds.).
25. Schwartz B., Harris A., Takamoto T., Kagemann L., Evans D., Chung H.S. Regional differences in optic disc and retinal circulation. Acta Ophthalmol. Scand. 2000, 78:627-631.
26. Sehi M., Tsui E., Cheng R., Wan J., Wong T., Dorner S., Fisher J., Hudson C. Relative magnitude of vascular reactivity in the major arterioles of the retina. Microvasc. Res. 2012, 83:200-204.
27. Urtti A., Pipkin J.D., Rork G., Sendo T., Finne U. Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbits. Int. J. Pharm. 1990, 61:241-249.
28. Vandewalle E., Abegão Pinto L., Olafsdottir O.B., Stalmans I. Phenylephrine 5% added to Tropicamide 0.5% eye drops does not influence retinal oxygen saturation values or retinal vessel diameter in glaucoma patients. Acta Ophthalmol 2012, 10.1111/j.1755-3768.2012.02545.x.
29. Venkataraman S.T., Hudson C., Fisher J.A., Flanagan J.G. Novel methodology to comprehensively assess retinal arteriolar vascular reactivity to hypercapnia. Microvasc. Res. 2006, 72:101-107.
30. Venkataraman S.T., Hudson C., Rachmiel R., Buys Y.M., Markowitz S.N., Fisher J.A., Trope G.E., Flanagan J.G. Retinal arteriolar vascular reactivity in untreated and progressive primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2010, 51:2043-2050.
31. Yoshida A., Feke G.T., Mori F., Nagaoka T., Fujio N., Ogasawara H., Konno S., Mcmeel J.W. Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am. J. Ophthalmol. 2003, 135:356-361.